In an interview, Mr Johnson advised that one other threatening variant of Covid-19 may set off a nationwide lockdown, warning that it could be “irresponsible” for any world chief to take action. This comes because the World Well being Organisation (WHO) issued a warning final week towards a brand new mutant ‘XE’ subvariant of Omicron, that seems to be extra transmissible than any pressure of the coronavirus.
Mr Johnson added that earlier lockdowns saved lives and he’s “not going to take any choice off the desk” if a brand new lethal variant arises.
In accordance with the Each day Beast, the XE subvariant is definitely a “recombinant” variant, which signifies that it is a “Frankenstein”-style product of the BA.1 and BA.2 subvariants of Omicron .
Experiences from the WHO and UK Well being Safety Company recommend that the brand new variant is 10 % extra transmissible than the BA.2 subvariant, which is already essentially the most contagious.
Mr Johnson instructed GB Information: “I wish to keep away from any such factor ever occurring once more.
“And I can not rule out one thing… I can not say that we would not be pressured to do a non-pharmaceutical intervention once more of the sort that we did.
“I feel it could be irresponsible of any chief, in any democracy to say that they’ll rule out one thing that would save life.
“And I consider that the issues that we did, saved lives, there could possibly be…
“I’ve received to be completely frank with you, there could possibly be a brand new variant, extra lethal, there could possibly be a variant that impacts kids badly that we actually have to include.
READ MORE: Covid hell: New Omicron XE variant sparks panic as China resorts to…
Mr Johnson added: “I am not going to take any choices off the desk, however I do not suppose it should occur.
“I feel we’re now within the section of… And that is the view of all of the advisors I discuss to, that we’re now within the section the place the virus is shedding its efficiency, total.
“And we have a massively vaccinated UK inhabitants.”
UKHSA’s chief medical advisor, Professor Susan Hopkins, stated: “This specific recombinant, XE, has proven a variable progress fee and we can’t but verify whether or not it has a real progress benefit.
“Thus far there’s not sufficient proof to attract conclusions about transmissibility, severity or vaccine effectiveness.”